Serum Endocan and Carotid Intima Media Thickness Evaluation in Vitiligo Patients | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 49, Volume 94, Issue 1, January 2024, Page 334-337 PDF (409.77 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2024.337174 | ||||
 View on SCiNiTO | ||||
| Abstract | ||||
| Background: Vitiligo is an acquired pigmentary disorder of the skin characterised by patches and circumscribed depigmented macules caused by epidermal melanocyte loss. A vasculoprotective molecule, endocan is an indicator of endothelial function. Objective: We aimed to evaluate carotid intima media thickness (CIMT) and serum endocan level in vitiligo patients and to compare their levels with healthy controls. Methods: This case-control study involved sixty male vitiligo patients aged 18 years or older, in addition to twenty healthy controls of the same age. A comprehensive evaluation of each patient included general and clinical examination, the Vitiligo Extent Tensity Index (VETI) score that was used to quantify the severity of vitiligo, a laboratory analysis to determine the serum endocan level, and Doppler ultrasound imaging of the CIMT. Results: No statistically significant differences were observed between the patient and control groups with respect to the age, gender, and body mass index. Patients had a significantly higher mean CIMT than the control group. Conclusion: Serum endocan and CIMT levels were significantly higher in vitiligo patients than in the control group and were significantly correlated with the severity of the disease, according to the study. | ||||
| Keywords | ||||
| Serum endocan; Carotid intima media thickness; Vitiligo patients; Epidermal melanocyte | ||||
|
Statistics Article View: 128 PDF Download: 171 |
||||
